Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 03, 2019 07:00 ET | Source: Active Biotech

Fas 2-studien LEGATO-HD med laquinimod i Huntingtons sjukdom presenteras på den vetenskapliga konferensen "American Academy of Neurology - AAN" i Philadelphia, PA, den 6 maj, 2019

PRESSMEDDELANDE Lund den 3 maj, 2019 - Active Biotech (NASDAQ STOCKHOLM: ACTI) meddelar att data från fas 2-studien LEGATO-HD med laquinimod i Huntingtons sjukdom har blivit utvalt att presenteras...
May 03, 2019 07:00 ET | Source: Active Biotech

The Phase 2 LEGATO-HD study of laquinimod in Huntington's disease will be presented at the scientific conference "American Academy of Neurology - AAN" in Philadelphia, PA, on May 6 2019

PRESS RELEASE Lund Sweden, May 3, 2019 - Active Biotech (NASDAQ STOCKHOLM: ACTI) announces that data from the Phase 2 LEGATO-HD study of laquinimod in Huntington's disease has been selected to be...
May 02, 2019 08:50 ET | Source: Active Biotech

The Election Committee of Active Biotech AB proposes Michael Shalmi to be appointed new Chairman of the Board and Uli Hacksell to be appointed new member of the Board

Active Biotech (NASDAQ, STOCKHOLM:ACTI) announce that the Election Committee of Active Biotech AB (publ) proposes that Michael Shalmi and Uli Hacksell are appointed new members of the Board of...
May 02, 2019 07:00 ET | Source: Active Biotech

Valberedningen i Active Biotech AB föreslår Michael Shalmi som ny styrelseordförande och Uli Hacksell som ny ordinarie styrelseledamot

PRESSMEDDELANDE Lund den 2 maj, 2019 - Active Biotech (NASDAQ, STOCKHOLM:ACTI) meddelar Valberedningens förslag till Årsstämman. Valberedningen för Active Biotech AB (publ) förslår att Michael...
May 02, 2019 07:00 ET | Source: Active Biotech

The Election Committee of Active Biotech AB proposes Michael Shalmi to be appointed new Chairman of the Board and Uli Hacksell to be appointed new member of the Board

PRESS RELEASE Lund 2 May, 2019 - Active Biotech (NASDAQ, STOCKHOLM:ACTI) announce that the Election Committee of Active Biotech AB (publ) proposes that Michael Shalmi and Uli Hacksell are...
April 26, 2019 05:00 ET | Source: Active Biotech

Årsredovisning 2018 Active Biotech AB (publ)

PRESSMEDDELANDE Active Biotechs årsredovisning för 2018 finns nu tillgänglig på www.activebiotech.com. Årsredovisningen kommer enbart att distribueras digitalt. Ladda ner som PDF Lund den 26...
April 26, 2019 05:00 ET | Source: Active Biotech

Annual Report 2018 Active Biotech AB (publ)

PRESS RELEASE Active Biotech's Annual Report 2018 is now available for download at www.activebiotech.com. The Annual Report will only be digitally distributed. The English version will be...
April 25, 2019 02:30 ET | Source: Active Biotech

Active Biotech AB - Delårsrapport januari - mars 2019

Kvartal 1 i korthet Active Biotechs partner NeoTX inleder ett kliniskt samarbete med AstraZeneca för utvärdering av ANYARA ("naptumumab") i kombination med IMFINZI® (durvalumab) i den...
April 25, 2019 02:30 ET | Source: Active Biotech

Active Biotech AB - Interim report January - March 2019

First quarter in brief Active Biotech's partner NeoTX entered clinical collaboration with AstraZeneca to evaluate ANYARA ("naptumumab") in combination with IMFINZI® (durvalumab) in the...
April 24, 2019 07:00 ET | Source: Active Biotech

Active Biotech: KALLELSE TILL ÅRSSTÄMMA

PRESSMEDDELANDE Styrelsen för Active Biotech AB (publ) har utfärdat kallelse till årsstämma, vilken kommer äga rum torsdagen den 23 maj 2019, klockan 17.00 i bolagets lokaler, Scheelevägen 22 i...